FASLG and cancer: Despite these limitations, our meta-analysis had significantly higher statistical power than the previous study that analyzed the association between the FASL -844C/T rs763110 polymorphism and cancer risk, since the cancer patients involved in our meta-analysis were twice as many as the previous one.